{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:32:28Z","timestamp":1773801148932,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.wneu.2023.04.089","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T02:31:30Z","timestamp":1682562690000},"page":"e1166-e1174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The Combination of Dopamine Agonist Treatment and Surgery May Be the Best Option in Challenging Prolactinoma Cases: A Single-Centre Experience"],"prefix":"10.1016","volume":"175","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1525-7613","authenticated-orcid":false,"given":"Dilan","family":"Demir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Numan","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2493-6068","authenticated-orcid":false,"given":"Cem","family":"Sulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6675-0160","authenticated-orcid":false,"given":"Guldana","family":"Zulfaliyeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6036-164X","authenticated-orcid":false,"given":"Semih Can","family":"Cetintas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hande Mefkure","family":"Ozkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinar","family":"Kadioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7785-8628","authenticated-orcid":false,"given":"Nurperi","family":"Gazioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Necmettin","family":"Tanriover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2023.04.089_bib1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jama.2016.19699","article-title":"Diagnosis and treatment of pituitary adenomas: a review","volume":"317","author":"Molitch","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.wneu.2023.04.089_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/B978-0-444-59602-4.00013-7","article-title":"Hyperprolactinemia and prolactinoma","volume":"124","author":"Romijn","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.wneu.2023.04.089_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2023.04.089_bib4","first-page":"1369","article-title":"Dopamine agonist-resistant prolactinomas","volume":"114","author":"Oh","year":"2011","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2023.04.089_bib5","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1530\/EJE-11-1000","article-title":"Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients","volume":"166","author":"Primeau","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.wneu.2023.04.089_bib6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.wneu.2012.06.024","article-title":"Pituitary tumor surgery: review of 3004 cases","volume":"79","author":"Loyo-Varela","year":"2013","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2023.04.089_bib7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11102-010-0283-y","article-title":"Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists","volume":"14","author":"Babey","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2023.04.089_bib8","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1210\/clinem\/dgz144","article-title":"Surgery as a viable alternative first-line treatment for prolactinoma patients. A systematic review and meta-analysis","volume":"105","author":"Zamanipoor Najafabadi","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2023.04.089_bib9","first-page":"814","article-title":"A\u00a0decade of pituitary microsurgery. The Herbert Olivecrona lecture","volume":"61","author":"Wilson","year":"1984","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2023.04.089_bib10","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.3171\/2012.6.FOCUS12125","article-title":"Norman Dott, Gerard Guiot, and Jules Hardy: key players in the resurrection and preservation of transsphenoidal surgery","volume":"33","author":"Patel","year":"2012","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.wneu.2023.04.089_bib11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.wneu.2023.04.089_bib12","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2265.2006.02493.x","article-title":"Influence of parasellar extension of macroprolactinomas defined by magnetic resonance imaging on their responsiveness to dopamine agonist therapy","volume":"64","author":"Delgrange","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.wneu.2023.04.089_bib13","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s11102-021-01168-x","article-title":"Surgery is a safe, effective first-line treatment modality for noninvasive prolactinomas","volume":"24","author":"Park","year":"2021","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2023.04.089_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EJE-07-0248","article-title":"Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients","volume":"158","author":"Kreutzer","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.wneu.2023.04.089_bib15","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/neuros\/nyy385","article-title":"Endoscopic transsphenoidal surgery of microprolactinomas: a reappraisal of cure rate based on radiological Criteria","volume":"85","author":"Micko","year":"2019","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2023.04.089_bib16","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1210\/jcem.87.7.8645","article-title":"Surgical treatment of prolactin-secreting pituitary adenomas: early results and long-term outcome","volume":"87","author":"Losa","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.wneu.2023.04.089_bib17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3389\/fendo.2020.00439","article-title":"Prolactinomas: prognostic factors of early remission after transsphenoidal surgery","volume":"11","author":"Zielinski","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.wneu.2023.04.089_bib18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00005792-199907000-00004","article-title":"Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients","volume":"78","author":"Gsponer","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.wneu.2023.04.089_bib19","first-page":"350","article-title":"Endonasal transsphenoidal approach for pituitary adenomas and other sellar lesions: an assessment of efficacy, safety, and patient impressions","volume":"98","author":"Zada","year":"2003","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2023.04.089_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF02989660","article-title":"Clinical management of prolactinomas: a ten-year experience","volume":"9","author":"Merola","year":"1992","journal-title":"Med Oncol Tumor Pharmacother"},{"key":"10.1016\/j.wneu.2023.04.089_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0090-3019(96)00452-1","article-title":"Endoscopic pituitary surgery: an early experience","volume":"47","author":"Jho","year":"1997","journal-title":"Surg Neurol"},{"key":"10.1016\/j.wneu.2023.04.089_bib22","first-page":"128","article-title":"The neurosurgical management of prolactinomas","volume":"44","author":"G\u00f6kalp","year":"2000","journal-title":"J\u00a0Neurosurg Sci"},{"key":"10.1016\/j.wneu.2023.04.089_bib23","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s007010170075","article-title":"Clinical features and medical treatment of male prolactinomas","volume":"143","author":"Asano","year":"2001","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.wneu.2023.04.089_bib24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11102-005-5087-0","article-title":"Combined treatment of invasive giant prolactinomas","volume":"8","author":"Yu","year":"2005","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2023.04.089_bib25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1530\/EJE-10-0961","article-title":"Surgical outcomes and prognostic factors of transsphenoidal surgery for prolactinoma in men: a single-center experience with 87 consecutive cases","volume":"164","author":"Qu","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.wneu.2023.04.089_bib26","doi-asserted-by":"crossref","first-page":"532","DOI":"10.4103\/0028-3886.84332","article-title":"Microsurgical management of prolactinomas - clinical and hormonal outcome in a series of 172 cases","volume":"59","author":"Sinha","year":"2011","journal-title":"Neurol India"},{"key":"10.1016\/j.wneu.2023.04.089_bib27","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s00701-012-1450-x","article-title":"Transsphenoidal surgery for microprolactinomas in women: results and prognosis","volume":"154","author":"Tamasauskas","year":"2012","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.wneu.2023.04.089_bib28","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1530\/EJE-12-0236","article-title":"Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients","volume":"167","author":"Vroonen","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.wneu.2023.04.089_bib29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3109\/02688697.2012.714817","article-title":"Medically treated prolactin-secreting pituitary adenomas: when should we operate?","volume":"27","author":"Vale","year":"2013","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.wneu.2023.04.089_bib30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11102-016-0723-4","article-title":"Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas","volume":"19","author":"Shimon","year":"2016","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2023.04.089_bib31","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ando.2016.07.004","article-title":"Long-term outcome of macroprolactinomas","volume":"77","author":"K\u00e9p\u00e9n\u00e9kian","year":"2016","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.wneu.2023.04.089_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11102-016-0766-6","article-title":"Significance of surgical management for cystic prolactinoma","volume":"20","author":"Ogiwara","year":"2017","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2023.04.089_bib33","doi-asserted-by":"crossref","first-page":"bvab074","DOI":"10.1210\/jendso\/bvab074","article-title":"Cure and hormonal control after prolactinoma resection: case series and systematic review","volume":"5","author":"Penn","year":"2021","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.wneu.2023.04.089_bib34","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00701-016-2762-z","article-title":"Reasons and results of endoscopic surgery for prolactinomas: 142 surgical cases","volume":"158","author":"Akin","year":"2016","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.wneu.2023.04.089_bib35","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00234-002-0774-2","article-title":"Gender-related differences in prolactin secretion in pituitary prolactinomas","volume":"44","author":"Nishioka","year":"2002","journal-title":"Neuroradiology"},{"key":"10.1016\/j.wneu.2023.04.089_bib36","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0090-3019(03)00012-0","article-title":"Growth potential of prolactinomas in men: is it really different from women?","volume":"59","author":"Nishioka","year":"2003","journal-title":"Surg Neurol"},{"key":"10.1016\/j.wneu.2023.04.089_bib37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11102-005-5079-0","article-title":"The epidemiology of prolactinomas","volume":"8","author":"Ciccarelli","year":"2005","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2023.04.089_bib38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/eje.0.1480325","article-title":"Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia","volume":"148","author":"Colao","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.wneu.2023.04.089_bib39","doi-asserted-by":"crossref","first-page":"8217","DOI":"10.3390\/ijms22158217","article-title":"Mechanisms of Central hypogonadism","volume":"22","author":"Barber","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.wneu.2023.04.089_bib40","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s11102-022-01242-y","article-title":"Proportion and predictors of hypogonadism recovery in men with macroprolactinomas treated with dopamine agonists","volume":"25","author":"Al Dahmani","year":"2022","journal-title":"Pituitary"},{"key":"10.1016\/j.wneu.2023.04.089_bib41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/cen.12124","article-title":"Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?","volume":"79","author":"Karavitaki","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.wneu.2023.04.089_bib42","doi-asserted-by":"crossref","first-page":"9930059","DOI":"10.1155\/2021\/9930059","article-title":"Surgery and medical treatment in microprolactinoma: a systematic review and meta-analysis","volume":"2021","author":"Lu","year":"2021","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.wneu.2023.04.089_bib43","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/jama.1984.03350070039020","article-title":"Long-term follow-up of transsphenoidal selective adenomectomy for prolactinoma","volume":"252","author":"Rodman","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.wneu.2023.04.089_bib44","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.surneu.2009.04.012","article-title":"Fully endoscopic transsphenoidal surgery for functioning pituitary adenomas: a retrospective comparison with traditional transsphenoidal microsurgery in the same institution","volume":"72","author":"D'Haens","year":"2009","journal-title":"Surg Neurol"},{"key":"10.1016\/j.wneu.2023.04.089_bib45","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jocn.2015.03.059","article-title":"Update on prolactinomas. Part 2: treatment and management strategies","volume":"22","author":"Wong","year":"2015","journal-title":"J\u00a0Clin Neurosci"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875023005740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875023005740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:20:33Z","timestamp":1761816033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875023005740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":45,"alternative-id":["S1878875023005740"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2023.04.089","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Combination of Dopamine Agonist Treatment and Surgery May Be the Best Option in Challenging Prolactinoma Cases: A Single-Centre Experience","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2023.04.089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}